REGISTEREO CHARtrY NUMBER: 257131
R•port ofth• Tru•t••* and
Unaudlt•d Fln•ncl*l Statwngnts
torth• Y••r End•d 31 D•c•mb•r 2023
Mldland• A•thma And All•rqy
Ro••4￿h Amoclallon
Boumè & Co.
Chartorod Acccrttntsnts
47a Queen Street
Derby
Derbyshire
DE1 3DE

Idlands A•thma And Alhryy
R•uorch A8socladon
Contents of th• Flnanclal Statemonts
for the Y•ar Ended 31 December 2023
R•wt ofth• Tru¥t••*
Ind•p•nd•nt Examln•rf• R•port
Stat•m•nt of Flnan¢lal Adlvl
Balanco Sho•t
Not•s to th Flnan¢lal Slat•m•nl•
7 to 11
D•talled Slat•m•nt of FIMn¢ial Actlvlll••
12

Trustees Annual Report for the perlod
1¥t January 2023 to 31st December 2023
nc• and Admlnlstrat14)n D•t•ll#
Charity Narne :_ Midlands Asthma aThJ Ajlergy Res8ar¢h Ass￿1￿￿1
othèr n8m8s by which rt 1$ knThn:_ MMRA
Reglsterad Ch8rfjty Numbèr
257131
Ind8Fendent &¥amlner
Boume & Co.
Chartered A¢cthJntants
47a Queen Street
Derby
Derbyshlre
DE13DE
Corr8spM)ndeneo addrgss
P.0 Box 1057
Lèit8stsr
LE2 3GZ
Nam98 ofthe Trust￿ vrt￿ manage th• eh•ritr.-
Mr Stuart Mi118
Dr Martin Siem
Mr St8phgn Watson
Mr P8t•rTeasdal8
l of*fiom actad as tnjstoas for thè whokg ygar.
The trust8•s are apwinted according to the Consltudon wh6ch stat•$ Ihat"{trust88818hall be elected by ony GenerBI Meeting
and sh811 serve unb"I Ihey dlo. ratire or unless Ihey ar8 removed from office by any subsequent Genetal Me8lng.
A key rnspon8itylty ofthe Trusto•s is to •nsurè that the public wll b￿￿￿frorn Iho r&saard) or prc4ect8 vthh we I￿}d.
tructurn G0￿manc•
ndm
The th8rity 18 governed by Ms conslSbJlOon which was I￿¢ ¢hanged in 2013 to rnfieet Ihe c*ang8s in the obJ8cts of thè t*arity.
refieclNJ thg cessaiK)n of medical tiials and the dfjspJ#•l of the forn￿r prernises in Vemon St. D•rby. Tr AB80cth had a
membershlp 0156 during Ihe year.
Tha eonstitybon $￿p￿lateS that the commltt8• ￿11 s*n*t ot.
The offlc8rs oflh8 Assooation, i.e. thg Patron, Pre61den( Chaim18n. VIc8-Chwnn8n, Twsurnrand S•cretaryele¢ted
at the Annual Genaral Mg8ting ofthg A¥80ryation and a Medical Nth¥sor. Al such officers shall be 818ettd for a fve-
year perfod and shall bo aliglblè for fe-818CtK)n for a fijrther p8rf¢>J of flva yaars after lh8 expiry of thè original five
Not mor• than avJht elected members. on• thlTrJ of ￿orn sh811 relre at ￿7¢h Annual g8n0T￿ MeefjThJ of th•
a&8ociation. Th8 mernb8r5 of th8 Commrttee lother than lh• aforgm8ntlc￿8d Patron, Presldant, Chairman, -
Chaimian, Tr8asur•r And SKr8tary to rebrg every three yoars and again each ofthe wght dect8d m•mbers shall be
enllll￿ lo Stand for rollelecdon fora fvrthertgrm of threo year8.
The Commrtte• may 018Ct m8mbewB to fill casual vacar￿A•S in officars and members of th• Cc¥nrrxtl89 unlil the
next Annual Genernl m88lng.
Tw$te98 and offic•rs ofth8 NAswdon o)nUnue to glve thtsirtimo vduntarity and recefve no remuneration or other beneffts.
Page 1

Actfv
ObJèets ofth¢ Asswation..
SponsorfrKJ of resaarch Snto the causes and Ireatm8nt ofAsthma and Mlergy. parbcularfy by earty career rgse8rthgr¥
b. Sponsotlng th& dlssamlnallon of thlgtothe publkan¢Yorto the rnediral professlon by publicalion orthrouqh ¥￿in￿r¥
or conferenc8S
Providing ger￿la1 infomi8tion on Asthrna and Alergy to Iha public.
d. Fu￿111ng raquasts for infomiation from academic bodles. Interestsd groups tho publk ￿ mattw5 rglatiThJ to
asthma and allefgy. IndudSng researc* findSrvJs and informallon gathered by the A8socaatson or ils ayants, at Iho
dlscretlon of the Execudve.
Und8rtako fijndrai￿n9 in SUPFQrt ofth8 objects a- d.
Summa
ofAdlVmI￿ uthkrt*k•n
The actmties of the Charity are largety dependent on the number and succ8ss of applleatlons for fundlng from methcal
researchers and instrtutions ir the East Midlands. The numter¥ of ap￿iCal)0n8 r8rnain low slnce Ihe of the pandemic.
We havè a sèparat8 M•dieal Advlc• Commrttee (MACI ehalred by Df Davlj Luyi crttic81ty OFPrni8•8 8pplieatkns.
IncludSng trhe amount of publlc benefft Ilkely to pK¢rue, in a¢o)rd8n¢g With thg Charity Cornmlsslon's gLtldanc6.
Awl8rKo Olap￿1¢*ic￿5 invofv88 a protC<3Jl Idèntyng d￿*￿ftg th16 ofauthortsaJon for dlffwentvaluos ofgr8nL indudlng
thè involvamènt of axtamal f•far￿ for hlgher value grants. Al MAC rec¥)rnmendation8 for fijnding ow £5k arè suw to
approval by a vots ofthe Execthve cx)rnmittee.
Our website
¥￿¥W maara.o
l is used to di5S8rninate infomiation about asthma and allergies to tha general public. It is also
Used to publici58 th& of Iha charity aThJ the research prctyects it sponsors. Th8 current websrtè Was 18St redesKJned in
2010 and gI￿n its aga, the Committee ¢Jechled to o)mmissN)n 8 new Sits whth improved rts k)cks, lunetionalty and security.
The slte went Ilve In lknbef 2023.
Athl•vem•nts and P•rfomMn
One apF41cafjon was approved by the MAC In thè Sum 01£89,796.12'.
The UK has onè of hlgh&st asthma d•ath rat6s in childrnn compared ￿ other devewd ¢xuntrios in the world. A rgpwt
publish8d 10 ￿r$ ago found that the rAr8 of c*iKlren with asthma in Ihe UK was poor.
Uslng electronic heath data which has alreaoty te8n ccdlected, this study wants to find out ff Ihe carn ofchildrtn with asthma
has improv8d in th8 10 years Since the report, Ir children from ￿rtain ethnic or swal bac*grounds are MO￿ likdy to die from
th•ir 85thma, and rf there are any risk facaors which ¢an pred￿1 Bsthma dè8th$.
Answering these questions wll allow h8althcare profv55hM#ls to better identy higher risk thi￿ren. improv• th8fjr (*fe, and
hopefvlty prevent asthma dealh3.
other proi¢¢ts wntinua from y•ars'.
ThèEn
onn
in th8 Britigh P lath)
It has ba8n Sho￿ that pauents wmh fc#)d aller*$ havo an impaim*nt li thak qualty of lrfe (QOLI. H￿ver, Iitue hAS been
done to prove Ihls relationship in dnjg allergy. In 2010, Bakgrdini and h8r group putAishgd th8 Orug Hyper58nstbwty auality of
L¢fe Qu8$tionnairo IDthy-Ql. Thi5 qu85tionnaiw was validated In an Ilalian population of 365 patiants. The D￿y￿ has shown
reprodwb18 rasutt5 when translatsd into Spanish. Portiiguese, Thai, Turkn¥h and Duteh. It is hyFthesised that ¢8pttJring and
addr8ssing patient in the UK through th8 use 01 th8 OrHy-a may improve the appr08ch to patients with drug alltrruy
andlorthe 8ffg¢tivon8ss of drug allergy tasting. Hv•rnv8r, th• DrHy-Q must first bg tran￿aled into English, ond then ¥￿kIated.
L*fore its use in the UK population can be conshler•Y.
Thls pr4ect Is 8¥p8Cted to LxJmpl&te in 2024.
Pagg 2

Inv•sl alon of mast cèlls from
th•ra
lfic bron
m8nt ofr
Severe lunoJntrd18dl asthma affgts a $ut4?t of people with a$thma and does Th)1 r•spond to eurront tr•almènts. Mast C8118
IMCI are a typo of white bbod etrll in the air%vay that play an irnportant rol8 in UfKontrolled asthma, causlng both day-t041ay
sympt(ms and attacks. Drugs that block MC funclton in asthma do Mt currenty 8XlSt, b8caus8 until now reseafchers have not
n ablg to Inv￿tigat9 thg mgch8nisms diiwng abnonnal MC fiJncJon. We wtll use a new techniqu8 called ¥illgle-¢oll RNA
uenLyng that will alkjw us to id8ntify the 8brK)rmal Mde￿Ier svJn8lling pathways that drlve abnomial MC lunction. Wg will
usé IACS obthinad frcm th• bnnchi of people with sgvgrg asthma and exF*Ct to uno)ver new ways which Mcs in a¥thma
be targeted 8ffecfvdy wtth now drugs, hwe• improwng the care for p80pI8 Vrith Ihis disease.
Th16 prO￿tI6 expethl to Lyjmpkn In 2024.
Tho Hary Morrow Bro*n Award ￿ an annual award c>)mm•morntlng lh8 daath tsflh8 fowKIgTofMAARA r( P￿￿d•S An onmal
Sum of £5.000 to support a fang¢ of health professionals wi8hlng to present at suttAt4& cOnf•mr￿ and 8ernlnarn. by paylNJ
butsaries cov8ring conferencg fegs and travel o%ts.
There has been an increase this year from the onè ap￿Seat￿n last year to fve applicati￿5 this year. Four applications wer8
approv¢d for thp to visit the Britssh Sockty lor Alergy and CliTh￿l Imrnundogy conference in Harrogata. On•
reUP￿nt visited the EUro￿n Rgspiratory Society intemational cmgmss in MAan. Al reawgnts we¥entsd thelr work In tho
field ofA81hma and Al¢rgy. The total 8¥pendrture on this wasiust over £3000.
Unrestrbcknl funds arn c#JrTenty £940,489 and usad to mogt ￿r IKqbilty in payTnent of agreed grants 8$ VAII a¥ Iho day-
day operating expenditure.
A d8￿￿￿5n was taken in 21)06 19 Inve8t 80me ol our fijnds In Invosb7)8nt acc￿nIS in ordgr to improve retums. Th￿6 frjnds
havo ￿rtoM1￿ wèll and w8 plan to Egavg th989 in place until the money they eontsln ar8 na•d•J our wcqk.
We hav& no funds matorially in doficit.
Our maln source offvn¢ts thls year has ag￿n by Ihdr Thatrjre. aro dlfflcult to prsdkt or budagt.
Tha tnK8t8os d•dar• that thèy havè oppr0￿￿ th8 tr￿1898. report at¥)ve
Signed on behaifofthe charfvs truste68
24th Juty 2024
S Watson . TNsts•
Page 3

lnd•￿nd0nt Ex•mln•rf• R•port t• th• Tr￿t•￿ of
MldlarTrd5 Asthma And All•r9y
R•search A•sock￿￿on
Ind•p•nd•nt •xamln•rf8 report to th• tN•tfj￿ of Mldland• A•thmo And Allgrgy R•8•arth A8•oelatlon
I rwrt to the tharity trustees on my examination ofthe accounts of Midlands Asthrna And Ajlew R858arch A88oU'ati(￿ (th•
Trust) for th8 yoar ended 31 DewThbor 2023.
R•sponslbllltk• and ￿1* of r•port
As thè chanty tru$t•$s tsfth• Tnjstyou ar• mponslb$8 forthe preparation ofthe accounts in thè rwlram8nts
of the Charib•s Ad 2011 Cthè AeVI.
I report in fesr*ct of my examin8tson of the Tr[￿￿8 accounts ￿￿lad out undw Saction 145 01 the Act and in Carr￿Trg out rny
examSnaJon I have fdknwed all appIl￿b￿8 Dwecbons given by the Charity Cammtssion under Sectlon 14515Mbl ofthe ACL
Ind•p•nd•nt •xamlMrf$ stat•m•nt
I h8Vg ￿MPleted my examination. l eefifim) that no mat8Ylal matters have come to my attention in win8eUon ¥￿th th•
examinati¢￿ gi¥ww me cau80 to bolh8¥e Ihat in any mat•rial rn$￿.
aec(Junting recLJrds *tre tv)t kept in respect of the Trwt as rg]uirgd by Sèdton 130 of the Act., or
the accounts do not accord wlh thos• r￿￿j$.. or
Ihe aftounts do not compty with the aP￿Icab￿ requimments concoming the fomi and content of 8CCDunts Set c
In the Charile$ (A￿Unts and Report51 Regulations 2008 othorthan any requirwnent that thg 9(xounts gNe a true
and falr ￿eW Is nota malter coniidarpd * part ofan Ind8￿r￿ant exanlnallon.
I have no ¢￿¢$m$ And ha￿ come acros6 no other matters in connectijn with the examination to wNch att8nOon shoukl be
dravm in Ihiy r8POrt in orderto en8￿6 a proper uThJeTsianding ofthe acc￿nts to be rgacw.
J¢8•ph Flty8tr1ck ACA
Boume & Co.
Chartered Accountants
47a (kn8n Street
Derfoy
Dorby5hirB
DE1 3DE
Dat•. %4.1.7Iuk.....................

Mfdland8 A8thma And All•rgy
Resear¢h AS*￿1￿tIOn
Statsm•nt of Flnanclal A¢llvttl••
for th• Y•ar End•d 31 O•e•mb•r 2023
2023
Unrosffic
fvnd
2022
Total
nds
Not8S
INCOME AND ENDOWMENTS FROM
Donations and legacies
S,172
90,468
Inveslm8nt ineomè
Total
EXPENDMJRE ON
Ralslng fijnds
24,2B7
Generat
63,338
Total
39,748
NET INCOMEIIEXPENDITIJRE)
Oth•r r￿09￿15#d galnsllloss•s1
Galnslllossasl on rèvaluatiort of o$89ts
15.0791
N•t mov•m•nt fund•
13.487
134,5981
RECONCIUATION OF FUNDS
Total funds brought foNRrd
927.002
981,600
TOTAL FUNDS CARRIED FORWARD
940.489
927,¢J)2
Th• not•s fonn part of these ffinandal statemonts
Page 5

Mldlands Asthma And AllwJy
Rovarch Assoclatlon
Balan￿ Sh••t
31 D￿•mb￿r 2021
2023
Unrestrthd
fund
2022
Totsl
fuThJs
Notgs
XED ASSETS
TaryitAe assets
Investsnents
729,440
710.874
729.442
710.876
CURRENT ASSETS
Dabtors
Cash at bank and in hond
717
212,265
172
219,406
212,982
219,578
CREOtroRS
Amounts falling due Iwthin one ygar
11.935)
13.4521
NET CURRENT ASSETS
216128
TOTAL AsseTS LEF￿ CURRENT LIA81LmES
927.C#)2
NET A%SEf3
940,489
927,C4)2
FUNDS
Unrestrictsd fijnds
940,489
TOTAL FUNDS
940,489
171h June 2024
Th• finandal slatements*we approved by the Board ofTn*tw and #ulhJrla•d for LIS￿ c￿ .............................................
and werg signed on its b8haKby.
S Walson- Tru$teg
Th8 notos fonn part ofthe89 finanthl stalornonts
Page 8

Mldlab)ds Asthma And All•rgy
R•8oarch A••oclallon
Not•• to th• Flnan¢l*l Stst•+n•nts
for th• Ymr End•d 31 D•ufflbgr 2023
ACCOUIfflNG POLICIES
B*sls ol pr•parlng tho Ilnanclal 8tst•rn•nts
The financkql ststements of the charity, which 18 a publlc b8n•fft tintity und8r FRS 102, have b8en pffjp8￿d in
acoirdan¢e vthh the CharitSes SORP IFRS 1021 AccwntiThJ and Repo￿ng by Charttias: Stat8rnent of
Recommended Pradce appllcabla to charibe8 pr8P8ring their a¢￿uTrts in acc￿r￿anC8 th8 Financi81 ReportiThJ
Standard applicab18 in the LIK and Republic of Iieland IFRS 1021 laffective 1 January 20191.. Finanoal Rèporting
Stsnda¥d 102 Th8 Finanryal Reporting Standard 8pplfe8blè in Ih8 UK and Republic of Ireland, and th8 Charibes
Act 2011. The financial statements have be8n prepared under the historical cost eonvèntion, ￿th lh8 excoplion of
investments ￿1¢h arn Indutlad at Ma￿0t valug, a¥ modhled by the revalu81I)n ol e•rtain a¥¥ots.
Incomo
I Inc¥)rne Is rwn1s8d In th8 Stat8m•nt of Financkql Actrvibes once the chartty has tntiugrngnl to the futNJs, it L8
pr0bfi￿e that th• inrjjmt vrill rKewed and the amount ran ￿ m•asur•d rgliabty.
Expendltur•
LwblllJ6s arg r80)gnls8d 8$axpèndllure a8srx)n asthwe ￿ alogal oreonstruckn obllgthn commlttlngth• thartty
to that ex￿nditurtr. it is probable that a transfer of economic t*neffts will be required in setuement and th8 amounl
of the obligation be rneasured reliably. Expenditttr8 is acownted for on an aceruals ba51$ and has been
dO￿ffied under headlngs that agg￿gate all cost r81at8d to tho r*legory. whe￿ eosts cannot b8 diredy ambuted
to partiwlar h8adings they havo baen allocated to Octivitigs on a basks ￿nSiStent vlith thg of reSou￿s.
Grants offered subi8Ctto condrfons whlch hav• not b#8n mot at the year end dats arg notsd as a ￿rnMIlment but
not accA￿d as expendtture.
Tanglbl• flx•d *M•ts
D•pwakn 1$ prowded at the f￿10th3 annual rat8¥ in orderto write off eath us8t ovgr its estimated us•ful lrfe.
Medical equipment
Computer equipmont
20% on reduring balance
33% on r¢durAng balan
Tttatlon
The charity i¥ gxempt from tax on its tharila￿a activthes.
Fund accoun￿n
unr8slit￿￿ fiJrKls ￿ be us8d In a¢xordan¢• Ihe charftsbl& obJ8etivas at thg diwelon ofth• truste0¥.
Restrictsd hjnds can oity b8 Usgd for parbcular restrict8d purposes wthin the objècts of th¢ charity. Reslrietion¥
arise ¥then sp8cffi8d by th8 donor OT when fvnds are rak88d for particular resthctad purwjses.
Furlhgr gWanatIc￿ ofthe naiwe and wrpos8 of each fijnd L8 induded in the nots8 to the fimnckql ¥laternents.
INVESTrIENT INCOME
2023
2022
Invg8tmen¢ In￿me
Deposit attount Intèrn
25.548
3,949
23,840
1.324
Pag• 7
¢Ontin￿l...

Mldlands Asthma And All•ryy
R￿•*r¢h Amocthtlon
Not•8 to th• Flnan¢lal Stat•m•nts- ¢ontlnugd
th• Y•ar End•d 31 OK•mbw 2023
TRUSTEES. REMUNERATION AND BENERTS
There We￿ no twstees, rem￿elatiOn or other bengfits for the ygor ondtyl 31 08e4mbèr 2023 nor for Iha year
•nd8d 31 December 2022.
Th￿e were no busts•8' expenses the year ended 31 Dwiber2023 nty for •nded
31 D8C8mb8r 2022.
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTi¥mES
Unfèsbthj
fund
INCOME AND ENDOWMENTS FROM
Donations and lagauas
Inveslment incon
25.164
T¢)l•l
EXPENDrruRE ON
Raislng funds
Charltabl• •dlvlU
General
Total
NET INCOME
Oth•r rncognlsed galn•lllo•M•)
G8insl(loss•sl on ravaluats"c￿ of fixed a¥80ts
N•t mov•rn•nt In lund•
134.5981
RECONCIUATION OF FUNDS
Totsl knnds brought forwwd
961,600
TOTAL FUNDS CARRIED FORWARD
TANGIBLE FIXED ASSETS
M•dtsl
equiwnont
Computsr
aqulpment
Tots
COST
At 1 January 2023 and 31 D￿Mb￿20T3
NET BOOK VALUE
At 31 December 2023
At 31 D￿mber 2022
Paga 8

Mklland• Asthrna And Alleryy
Research Assoclatlon
Not•s to th• FIMncl•l Stat•m•nts- ¢ontlnu•d
forth• Y•ar End•d 31 D•c•rnlJ•r 2023
FtXED ASSET INVESTMENTS
Listsd
invastmènts
MARKEf VALUE
Al 1 January 2023
R•valualions
710,874
18.5e6
At 31 December 2023
729,440
NET 800K VALUE
At 31 D￿￿￿b￿r 2023
729.440
At 31 Downb8r 2022
710 874
Thor• w•r• no Invastment ass•ts outsk10 th• UK.
Cost or valMlon at 31 Docombor 2023 Is rapr￿ant8d by..
Listed
In￿trnents
Valualon In 2023
18,566
710,874
729,440
DEBTORS: AMOUNTS FALUNG DUE WIThIN ONE YEAR
2023
2022
Deblcrfs and Prepay￿nts
717
172
CREDrroRS: AMOUNTS FALLING DUE WITHIN ONE YEAR
20fJ
2022
3,452
MOVEMENT IN FUNDS
movement
In funds
At
31.12.23
At1.1.23
Unrestrf¢t•d fvnd•
General fijnd
927,002
13.487
TOTAL FUNDS
927 002
Net nNMrnent In filnds, indudèd in the Bbovg are as frAk)￿..
IncomiThJ
Resources
8xpandgd
Gains and
Mov8mont
In funds
Unr••trlct•d lund•
General fund
139.7481
18,566
13.487
TOTAL FUNDS
Pag& 9

Mldl•nds Asthrn• And All•r
R•s￿rth Atsoclatlon
Not•• to th• Flnancl•l Stat•mgnts- ¢ontlnu•d
for th• Y••r End•d 31 0￿•mts•r 2023
MOVEMENT IN FUNDS- contlnu•d
Comp•r•tlv•• for mov•m•nt In fund•
Net
mowm8nt
in fvnds
At
31.12.22
At1.1.22
UnreBtrICt￿ fund•
General fvnd
961.6CIJ
134.5981
927,002
TOTAL FUNDS
961,6C4J
34,5981
927,002
Comparaty8 net [rK)Ve￿nI In fiJnd$. induded in thfj abovè or* as follow&".
Incoming
rosourcey 8xp8nd#d
Gabn8 and
loss•s
M¢)vemgnt
In fvnds
Unrn$tri¢t•d funds
General lund
115,832
186,1841
164.0481
134,5981
TOTAL FUNDS
115,632
86,184
34,5981
A currgnt yg#r 12 rnonths and w•)r y•ar 12 nKJnlhs combln8d ￿￿On is as foll¢yK.'
Net
rn￿ment
In funth
At1.1.22
31.12.23
UnrMtrfct•d fund•
General fund
961.6[
121,111)
940.489
TOTAL FUNI)S
961,600
21.1111
940,489
A ¢uThent year 12 nK)nlhs and prfof 12 months fxjmblned net movernenl in fvnds. indudèd In above are
as fdlows..
In¢omiryJ
resourcos
Rewur
expended
Gains And
loss&s
n funds
Unr•8trfetsd fvb)ds
Gener81 bjnd
150,301
1125.932}
{45.4801
121,111}
TOTAL FUNDS
1125 9321
21 1111
Pap 10
rJ)nOnued...

Mldlands Asthma And All•ryy
R•s•areh Asso¢latlon
Not•• to th• Flnanclal Slat•m•nts- contlnu•d
for th• Y•ar End•d 31 Doe•m￿r 2023
10.
RELATED PARTY DISCLOSURES
There were no related party tran6ac￿OnS for the year ende4J 31 D8¢xmbèr 2023.
Pag? 11

Idl•nd• A•thm* And All•rgy
R•8•ar¢h As•od4tlon
D•tallod Stat•rn•nt ot FIr￿n￿lI Acvvlu
forth• Y•ar ended 31 D•c•mb•r 2023
2023
2022
INCOME AND ENDOWMENTS
Donatlons and l•g•cl•s
Donations
Legaaes
M8mbw5 su1￿crip1￿Jns
4,629
153
2.257
88,151
60
5,172
Inv•*tm•nt Ineom•
Investment Inry)me
DaposK account Int8r•st
25,548
23,840
29.497
25,164
Total Incomlnq Mour¢•s
34,669
115.632
EXPENDrruRE
Ralslng donatlom •nd1•gacl••
Wages
Rates and watsr
Insuran
Telephona
Sta*'onery, winting, FQStage and ad¥erb'sing
Sundrfas
18.329
1.320
2.320
17,8¥2
1,440
439
2.127
287
1.834
24.287
Charft•bl• actlvltl••
Aerobiokngy Contrd
Other Researth Grants
9,048
36,600
23.523
12,079
60,1r3
Support ¢08t•
Fln*n
Bank chary&¥
1fj0
Gov•mJnu ¢o•t•
Aeo)untancy
3.067
Totsl resources eX￿d￿j
N•t l•xp•nd1tur•￿nmrn•
Th18 page dog$ notfDmi part of tho sta￿tOry fina￿4 ststements
Page 12